DoD Multiple Sclerosis, Exploration- Hypothesis Development Award | W81XWH 18 MSRP EHDA

Opportunity Information: Apply for W81XWH 18 MSRP EHDA

The DoD Multiple Sclerosis (MS) Exploration - Hypothesis Development Award (Funding Opportunity Number W81XWH-18-MSRP-EHDA) is a Department of Defense research funding mechanism designed to help investigators test bold, early-stage ideas in the multiple sclerosis field. It is run through the Department of Defense, Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA), and sits within a science and technology/research and development funding category (CFDA 12.420). The core purpose of the program is to support the initial exploration of innovative, high-risk, high-gain concepts that could be genuinely transformative for MS research, especially ideas that are not yet mature enough to be supported by more traditional grant programs.

The award is specifically geared toward hypothesis-driven research. Applicants are expected to propose a clearly stated, testable hypothesis and to back it up with a strong scientific rationale and a thoughtful study design. A key feature of this opportunity is that preliminary data are not required, which signals that the program is intentionally trying to lower the barrier for unconventional or emerging concepts that may not yet have extensive proof-of-concept results. Even without preliminary results, the proposal still needs to be rigorous: the hypothesis should be well formulated, the experimental approach should be coherent and defensible, and the project should be structured in a way that generates interpretable outcomes that can guide next steps.

Innovation is the central selection theme, and the solicitation draws a firm line between truly novel work and routine extensions of existing research. Competitive proposals are expected to do more than add incremental knowledge on top of published findings or ongoing projects. Instead, they should introduce a new paradigm, challenge prevailing assumptions, reframe persistent problems from a fresh angle, or apply a distinctly creative approach that could open up new lines of investigation in MS. The program makes it the Principal Investigator's responsibility to explain, directly and explicitly, what makes the work innovative in the MS research landscape. In practice, that means reviewers will be looking for a convincing argument that the project is not simply "next-step" science, but something with the potential to shift thinking or create new opportunities for the field.

Another defining goal is that funded studies should lay the groundwork for future research. This award is positioned as an entry point that helps generate early findings, feasibility signals, or conceptual clarity that can support later, larger, or more definitive studies. The expectation is not necessarily that the project will immediately deliver a clinical breakthrough, but that it will meaningfully de-risk a novel idea, establish a new direction, or provide a foundation that enables follow-on funding and expanded scientific investigation.

From an administrative standpoint, the opportunity was listed as discretionary funding and allowed for either a grant or a cooperative agreement as the funding instrument type, depending on the government’s intended level of involvement. Eligibility was described as "unrestricted," meaning it was open to a broad range of applicant organizations, subject to any additional eligibility details that may have been provided in the full announcement text. The opportunity record shows an anticipated number of about six awards. The posting was created May 4, 2018, with an original closing date of October 18, 2018. The listed award ceiling appears as 0 in the summary record, which typically indicates that the ceiling was either defined elsewhere in the full solicitation or was not captured in that specific database field rather than implying no funding.

Overall, this award can be understood as a targeted DoD investment in early, creative MS research that might be too speculative for conventional mechanisms, provided it is still anchored by a solid hypothesis and a credible plan. The strongest applications are those that clearly articulate what is genuinely new, why it matters for MS, and how the proposed work will produce foundational insights that can propel the research area forward.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Multiple Sclerosis, Exploration- Hypothesis Development Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on May 04, 2018.
• Applicants must submit their applications by Oct 18, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 6 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 18 MSRP EHDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: